Dr. Richard H. LeConey, MD Joins PranaX Corporation as Chief Medical Officer Leading the Way in Regenerative Medicine PranaX Corporation has appointed Dr. Richard H. LeConey, MD, as Chief Medical Officer, enhancing their focus on regenerative biologics and wellness.

Dr. Richard H. LeConey, MD Joins PranaX Corporation as Chief Medical Officer Leading the Way in Regenerative Medicine #USA #Houston #regenerative_medicine #PranaX #Dr._LeConey

PranaX Corporation Secures $17 Million to Advance Exosome Technology in Regenerative Medicine PranaX Corporation has successfully closed a $17 million Series A financing round to enhance its research in regenerative biologics, focusing on exosomes.

PranaX Corporation Secures $17 Million to Advance Exosome Technology in Regenerative Medicine #United_States #Houston #regenerative_medicine #exosome_technology #PranaX

PranaX's Exosome Technology Gains Attention in Nature Communications Journal A recent publication in Nature Communications highlights PranaX's licensed exosome technology, marking a significant step in regenerative medicine advancements.

PranaX's Exosome Technology Gains Attention in Nature Communications Journal #USA #Houston #regenerative_medicine #exosome_technology #PranaX

PranaX Corporation Welcomes Phillip Maderia as New CEO to Propel Exosome Innovations PranaX Corporation has appointed Phillip Maderia as CEO. With a strong background in exosome technology, he aims to enhance health through innovative solutions.

PranaX Corporation Welcomes Phillip Maderia as New CEO to Propel Exosome Innovations #USA #Houston #exosome_technology #PranaX #Phillip_Maderia